Accendra Health/$ACH
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Accendra Health
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
- Ticker
- $ACH
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 6,500
- Headquarters
- Glen Allen, United States
- Website
- www.accendrahealth.com
Accendra Health Metrics
BasicAdvanced
$16M
-
-$2.24
1.62
-
Price and volume
Market cap
$16M
Beta
1.62
52-week high
$4.69
52-week low
$0.19
Average daily volume
3.3M
Financial strength
Current ratio
0.408
Quick ratio
0.199
Long term debt to equity
-3.133
Total debt to equity
-3.258
Interest coverage (TTM)
0.09%
Profitability
EBITDA (TTM)
242.79
Gross margin (TTM)
44.13%
Net profit margin (TTM)
-6.72%
Operating margin (TTM)
0.47%
Effective tax rate (TTM)
17.30%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
0.24%
Return on equity (TTM)
24.64%
Valuation
Price to revenue (TTM)
0.006
Price to book
-0.03
Price to tangible book (TTM)
-0.01
Price to free cash flow (TTM)
-0.076
Free cash flow yield (TTM)
-1,316.83%
Free cash flow per share (TTM)
-2.674
Growth
Revenue change (TTM)
-7.14%
Earnings per share change (TTM)
-87.09%
3-year revenue growth (CAGR)
-37.05%
10-year revenue growth (CAGR)
-12.63%
3-year earnings per share growth (CAGR)
13.10%
10-year earnings per share growth (CAGR)
2.07%
What the Analysts think about Accendra Health
Analyst ratings (Buy, Hold, Sell) for Accendra Health stock.
Analyst projections of the future price of Accendra Health stock.
Accendra Health Financial Performance
Revenues and expenses
Accendra Health Earnings Performance
Company profitability
Upcoming events
No upcoming events
Accendra Health News
AllArticlesVideos
Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
Business Wire6 days ago
Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders' Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard
Business Wire1 week ago
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Business Wire4 weeks ago
Funds containing Accendra Health
Fund name | Fund size | $ACH weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.00% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.